A recent clinical trial funded by the National Heart, Lung, and Blood Institute (NHLBI) shows promise for treating a rare and painful genetic disease called Arterial Calcification Due to Deficiency
News & Updates
A University of Liverpool project has received a significant boost in its fight against major diseases. Unitaid, a global health organization, awarded over £6 million to the initiative, titled LONGEVITY.
Cadrenal Therapeutics' Tecarfarin Scores Orphan Drug Designation for Preventing Blood Clots in Heart Assist Device Patients Cadrenal Therapeutics, a biopharmaceutical company developing innovative blood thinners, recently announced a significant development
Every year, the issue of executive compensation in Big Pharma comes under close scrutiny. This year is no different, as publicly traded companies reveal the total compensation packages for their
Researchers at The Royal Marsden, partnering with Guardant Health, have developed a groundbreaking liquid biopsy test called Marsden360. This simple blood test offers significant advantages for lung cancer patients, the
Avutometinib, a drug designed to target a specific pathway in cancer cells, has received orphan drug designation from the FDA for recurrent low-grade serous ovarian cancer. This designation is given
The European Medicines Agency (EMA) has taken a significant step towards ensuring the safety of medications by updating its recommendations for testing N-nitrosamines, a class of chemicals linked to an
The Medicines and Healthcare products Regulatory Agency (MHRA) of the United Kingdom has granted marketing authorization for Quizartinib (Vanflyta) as first-line therapy in conjunction with standard chemotherapy for adult patients
The Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has approved etrasimod (brand name Velsipity) for treating adults (over 16) with moderate to severe ulcerative colitis. This chronic
This article highlights a significant advancement in diabetes management with the FDA approval of Deka Research & Development's novel automated insulin pump, the twiist. Designed specifically for those living with
The FDA has approved a new medication called Tryvio (aprocitentan) for adults with high blood pressure that is difficult to control with existing therapies. Tryvio works differently than current medications
The Bill & Melinda Gates Medical Research Institute (Gates MRI) announced the start of a Phase 3 clinical trial to evaluate a new tuberculosis (TB) vaccine candidate, M72/AS01E. This is